Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multiple myeloma patients

British Journal of Haematology

Volumn 159, Issue 1, 2012, Pages 111-113

  Minarik, Jiri ^a   Pika, Tomas ^a   Bacovsky, Jaroslav ^a   Langova, Katerina ^a   Scudla, Vlastimil ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Acyclovir; Bortezomib; Herpes zoster; Multiple myeloma; Prophylaxis

Indexed keywords

ACICLOVIR; BORTEZOMIB;

ADULT; AGED; ANTIVIRAL THERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HERPES ZOSTER; HUMAN; INFECTION PREVENTION; LETTER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VIRUS REACTIVATION;

ACYCLOVIR; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; BORONIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PYRAZINES; RETROSPECTIVE STUDIES;

EID: 84866325630     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09233.x     Document Type: Letter

References (10)

1. Argyriou, A.A., Iconomou, G. & Kalofonos, H.P. (2008) Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood, 112, 1593-1599.
2. Chanan-Khan, A., Sonneveld, P., Schuster, M.W., Stadtmauer, E.A., Facon, T., Harousseau, J.L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., Neuwirth, R., Anderson, K.C. & Richardson, P.G. (2008) Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. Journal of Clinical Oncology, 26, 4784-4790.
3. Kim, S.J., Kim, K., Do, Y.R., Bae, S.H., Yang, D.-H. & Lee, J.-J. (2011) Low-dose acyclovir is effective for prevention of herpes zoster in myeloma patients treated with bortezomib: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study. Japanese Journal of Clinical Oncology, 41, 353-357.
4. Kropff, M., Bisping, G., Schuck, E., Liebisch, P., Lang, N., Hentrich, M., Dechow, T., Kroger, N., Salwender, H., Metzner, B., Sezer, O., Engelhardt, M., Wolf, H.H., Einsele, H., Volpert, S., Heinecke, A., Berdel, W.E. & Kienast, J. (2007) Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma. British Journal of Haematology, 138, 330-337.
5. Mateos, M.V., Hernandez, J.M., Hernandez, M.T., Gutierrez, N.C., Palomera, L., Fuertes, M., Diaz-Mediavilla, J., Lahuerta, J.J., de la Rubia, J., Terol, M.J., Sureda, A., Bargay, J., Ribas, P., de Arriba, F., Alegre, A., Oriol, A., Carrera, D., Garcia-Larana, J., Garcia-Sanz, R., Blade, J., Prosper, F., Mateo, G., Esseltine, D.L., van de Velde, H. & San Miguel, J.F. (2006) Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study. Blood, 108, 2165-2172.
6. Pour, L., Adam, Z., Buresova, L., Krejci, M., Krivanova, A., Sandecka, V., Zahradova, L., Buchler, T., Vorlicek, J. & Hajek, R. (2009) Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib. Clinical Lymphoma Myeloma and Leukemia, 9, 151-153.
7. Richardson, P.G., Sonneveld, P., Schuster, M.W., Irwin, D., Stadtmauer, E.A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., San Miguel, J.F., Blade, J., Boccadoro, M., Cavenagh, J., Dalton, W.S., Boral, A.L., Esseltine, D.L., Porter, J.B., Schenkein, D. & Anderson, K.C. (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. New England Journal of Medicine, 352, 2487-2498.
8. San Miguel, J.F., Schlag, R., Khuageva, N.K., Dimopoulos, M.A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M.T., Palumbo, A., Samoilova, O.S., Dmoszynska, A., Abdulkadyrov, K.M., Schots, R., Jiang, B., Mateos, M.-V., Anderson, K.C., Esseltine, D.L., Liu, K., Cakana, A., van de Velde, H. & Richardson, P.G. (2008) Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. New England Journal of Medicine, 359, 906-917.
9. Swaika, A., Paulus, A., Miller, K.C., Sher, T., Almyroudis, N.G., Ball, D., Wood, M., Masood, A., Lee, K. & Chanan-Khan, A.A. (2012) Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients. Journal of Supportive Oncology, 10, 155-159.
10. Vickrey, E., Allen, S., Mehta, J. & Singhal, S. (2009) Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy. Cancer, 115, 229-232.